Citius Oncology Stock (NASDAQ: CTOR) stock price, news, charts, stock research, profile.
Open | $1.74 |
Close | $1.88 |
Volume / Avg. | 110.77K / 409.36K |
Day Range | $1.70 - $1.93 |
52 Wk Range | 1.53 - 4.42 |
Market Cap | $129.06M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 27 |
Short Interest | - |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Citius Oncology (NASDAQ:CTOR) through any online brokerage.
Other companies in Citius Oncology’s space includes: Anixa Biosciences (NASDAQ:ANIX), Adverum Biotechnologies (NASDAQ:ADVM), bluebird bio (NASDAQ:BLUE), Adicet Bio (NASDAQ:ACET) and aTyr Pharma (NASDAQ:ATYR).
Citius Oncology has a consensus price target of $6.00.
The stock price for Citius Oncology (NASDAQ: CTOR) is $1.81 last updated September 5, 2024 at 6:47 PM EDT.
There are no upcoming dividends for Citius Oncology.
Citius Oncology’s Q4 earnings are confirmed for Thursday, November 21, 2024.
There is no upcoming split for Citius Oncology.
Citius Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.